Personalized health applies precision medicine principles—tailoring interventions based on individual biological variation—to understand how genetic, metabolic, and environmental factors shape human responses to diet and treatment. In plant science, this concept drives research into how phytochemicals, nutrients, and bioactive plant compounds interact differently with individual genetic profiles and gut microbiomes, informing the development of crops and plant-based therapies optimized for specific health outcomes. This intersection highlights the growing role of plant-derived compounds in nutrigenomics and personalized nutrition strategies.
A review study found that plants we eat and use as medicine directly shape the community of bacteria living in our gut, and those bacteria in turn change how our bodies process both food and drugs — with real consequences for treating chronic diseases.
1
Plant-derived foods and medicines interact with gut microbiota to produce bioactive metabolites that directly influence host signaling pathways and therapeutic outcomes.
2
The gut microbiome plays a measurable role in drug metabolism and resistance to therapy, meaning microbiome composition can predict or alter how well a patient responds to treatment.
3
Microbiome analysis is identified as a tool for improving diagnosis, disease monitoring, and personalized medical strategies for chronic diseases.
mail
Weekly plant science — one email, Saturdays.
Check your inbox to confirm — link expires in 24 hours.
Something went wrong — please try again.
Too many signup attempts from your network. Try again in an hour, or email hello@plant.news.